Publication Cover
Expert Review of Precision Medicine and Drug Development
Personalized medicine in drug development and clinical practice
Volume 4, 2019 - Issue 3
90
Views
2
CrossRef citations to date
0
Altmetric
Drug Profile

Gilteritinib for the treatment of patients with FLT3 mutated relapsed or refractory acute myeloid leukemia

Pages 105-112 | Received 13 Feb 2019, Accepted 25 Apr 2019, Published online: 13 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Katsuhiro Miura, Noriyoshi Iriyama, Yoshihiro Hatta & Masami Takei. (2021) Personalized patient care with aggressive hematological malignancies in non-responders to first-line treatment. Expert Review of Precision Medicine and Drug Development 6:3, pages 203-215.
Read now

Articles from other publishers (1)

Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, Emma McInturff, Sarah J. Fink, Christopher J. Helal, Jacob C. DeForest, Peter D. Morse, Subham Mahapatra & Christopher J. O’Donnell. (2020) Synthetic Approaches to New Drugs Approved during 2018. Journal of Medicinal Chemistry 63:19, pages 10652-10704.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.